Interestingly, Flynn et al. found that particularly ALT-positive cancer cells are hypersensitive to pharmacological inhibition of ATR, one of the main DNA damage checkpoint-activating kinases in human cells [35, 53]. The gene discussed is ATR; the disease is cancer.